Staging procedures in patients with mucinous borderline tumors of the ovary do not reveal peritoneal or omental disease.
暂无分享,去创建一个
J. Bart | L. Kooreman | L. Massuger | R. Kruitwagen | M. Kleppe | A. Kruse | K. De Decker | H. T. ter Brugge | Stephanie Speth
[1] V. Cogliano. International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.
[2] L. Denny,et al. FIGO Cancer Report 2018 , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[3] I. Christensen,et al. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT). , 2016, Gynecologic oncology.
[4] M. Quinn,et al. FIGO Cancer Report 2015 , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[5] V. Turan,et al. Should we remove the normal-looking appendix during operations for borderline mucinous ovarian neoplasms?: A retrospective study of 129 cases. , 2015, International journal of surgery.
[6] O. Mogensen,et al. The Value of Random Biopsies, Omentectomy, and Hysterectomy in Operations for Borderline Ovarian Tumors , 2014, International Journal of Gynecologic Cancer.
[7] K. K. van de Vijver,et al. Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature. , 2014, Gynecologic oncology.
[8] R. Kurman,et al. WHO classification of tumours of female reproductive organs , 2014 .
[9] N. Teng,et al. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer. , 2013, Gynecologic oncology.
[10] L. Selvaggi,et al. Borderline Epithelial Tumors of the Ovary , 2013 .
[11] J. Berek,et al. Cancer of the ovary, fallopian tube, and peritoneum , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[12] E. Darai,et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. , 2012, The Lancet. Oncology.
[13] P. Suprasert,et al. Accuracy of Frozen-Section Diagnosis of Ovarian Mucinous Tumors , 2012, International Journal of Gynecologic Cancer.
[14] I. Shih,et al. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. , 2011, Human pathology.
[15] P. Suprasert,et al. Mucinous Tumor of Low Malignant Potential (“Borderline” or “Atypical Proliferative” Tumor) of the Ovary: A Study of 171 Cases With the Assessment of Intraepithelial Carcinoma and Microinvasion , 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[16] J. Baak,et al. Neoplastic transformation of endocervicosis into an extraovarian mucinous cystadenocarcinoma. , 2011, Human pathology.
[17] R. Kurman,et al. The Fallopian Tube-Peritoneal Junction: A Potential Site of Carcinogenesis , 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[18] C. Haie-meder,et al. Prognostic Factors of a Large Retrospective Series of Mucinous Borderline Tumors of the Ovary (Excluding Peritoneal Pseudomyxoma) , 2010, Annals of Surgical Oncology.
[19] Kathleen R. Cho,et al. Ovarian cancer update: lessons from morphology, molecules, and mice. , 2009, Archives of pathology & laboratory medicine.
[20] A. Ayhan,et al. Omentectomy for gynecologic cancer: how much sampling is adequate for microscopic examination? , 2007, Archives of pathology & laboratory medicine.
[21] P. Neven,et al. Management of borderline ovarian neoplasms. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Brännström,et al. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period , 2007, International Journal of Gynecologic Cancer.
[23] M. Casparie,et al. Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[24] S. Robboy,et al. Is Stromal Microinvasion in Primary Mucinous Ovarian Tumors With “Mucin Granuloma” True Invasion? , 2007, The American journal of surgical pathology.
[25] N. Yaegashi,et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours , 2006, British Journal of Cancer.
[26] P. Morice,et al. Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. , 2004, European journal of cancer.
[27] E. Daraï,et al. Restaging surgery for women with borderline ovarian tumors , 2004, Cancer.
[28] R. Young,et al. The Distinction Between Primary and Metastatic Mucinous Carcinomas of the Ovary: Gross and Histologic Findings in 50 Cases , 2003, The American journal of surgical pathology.
[29] J. Nicklin,et al. Evaluation of restaging in clinical stage 1A low malignant potential ovarian tumours , 2002, The Australian & New Zealand journal of obstetrics & gynaecology.
[30] C. Mangioni,et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] M. McKay,et al. Cancer of the ovary. , 1994, The New England journal of medicine.
[32] G. Stuart,et al. Evaluation of surgical staging in stage I low malignant potential ovarian tumors. , 1991, Gynecologic oncology.